| 21/68 | US=110 / Câncer Abrams JS, Christian M, Doroshow JH. Structures supporting cancer clinical trials. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 327-35. ISBN 978-0-443-06695-5. NEOPLASIAS; CANCER; ENSAIOS CLINICOS; INSTITUTO NACIONAL DO CANCER; INDUSTRIA BIOFARMACEUTICA |
| 22/68 | US=110 / Câncer Talmadge JE, Cowan KH. Gene therapy in oncology. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 513-30. ISBN 978-0-443-06695-5. NEOPLASIAS; CANCER; TERAPIA GENICA; VETORES; TERAPIA GENETICA DIRIGIDA; ENSAIOS CLINICOS |
| 23/68 | US=9 / Pediatria Berg SL, Sather H, Ellenberg SS. Cancer clinical trials: design, conduct, analysis, and reporting. In: Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins, 2006. p. 501-24. ISBN 978-0-7817-5492-7. ONCOLOGIA PEDIATRICA; CANCER INFANTIL; CRIANCA; ENSAIOS CLINICOS; CONDUTA; DESENHO; ANALISE; RELATORIOS |
| 24/68 | US=13 / Biol/Mol Pecorino L. Introduction. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 1-19. ISBN 978-0-19-921148-7. CANCER. DEFINICAO; CARACTERISTICAS DO CANCER; CRESCIMENTO CELULAR; APOPTOSE; ONCOGENE; GENES SUPRESSORES DE TUMOR; CARCINOGENESE; FATORES DE RISCO; CANCER. TERAPIA; ENSAIOS CLINICOS; ALVOS MOLECULARES |
| 25/68 | US=13 / Biol/Mol Pecorino L. The cancer industry: drug development and clinical trial design. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 259-73. ISBN 978-0-19-921148-7. INDUSTRIA DO CANCER; DESENVOLVIMENTO DE DROGAS; ENSAIOS CLINICOS; DESENVOLVIMENTO DA IMATINIBA; FARMACOGENOMICA |
| 26/68 | US=6 / Transplante Perin EC, Silva GV, Fernandes MR. Regenerative medicine: application in cardiovascular diseases. In: Soiffer RJ. Hematopoietic stem cell transplantation. 2nd ed. New Jersey: Humana Press, 2008. p. 713-24. ISBN 978-1-934115-05-3. MEDICINA REGENERATIVA; DOENCAS CARDIOVASCULARES; ENTREGA DE CELULAS ESTAMINAIS TERAPEUTICAS; SEGURANCA DA TERAPIA DE CELULAS-TRONCO; ENSAIOS CLINICOS; DOENCA CARDIACA ISQUEMICA; INSUFICIENCIA CARDIACA; MIOBLASTOS ESQUELETICOS; INFARTO DO MIOCADIO |
| 27/68 | US=17 / Gastro Velin D, Michetti P. Future prospects for helicobacter pylori vaccination. In: Wang TC, Fox JG, Giraud AS. The biology of gastric cancers. New York: Springer, 2008. p. 601-20. ISBN 978-0-387-69181-7. CANCER GASTRICO; HELICOBACTER PYLORI; VACINA; ENSAIOS CLINICOS |
| 28/68 | US=28 / Biol/Mol Kerbel RS, Emmenegger U, Folkins C, Munoz R, Shaked Y. Metronomic low-dose antiangiogenic chemotherapy in mice and man. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 277-96. ISBN 978-1-58829-870-6. BAIXA DOSE DE QUIMIOTERAPIA; ANGIOGENESE TUMORAL; TERAPIA ANTIANGIOGENICA; ENSAIOS CLINICOS; CELULAS PROGENITORAS ENDOTELIAIS; VEGF; METASTASE; CANCER DE MAMA; CANCRO DO OVARIO; CICLOFOSFAMIDA |
| 29/68 | US=28 / Biol/Mol Eder JP, Zuckerman DS. Endpoints for the determination of efficacy of antiangiogenic agents in clinical trials. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 509-24. ISBN 978-1-58829-870-6. |
| 30/68 | US=28 / Biol/Mol Clamp AR, Jayson GC. The role of imaging in the clinical development of antiangiogenic agents. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 525-36. ISBN 978-1-58829-870-6. ANGIOGENESE; ENSAIOS CLINICOS; IMAGEM; ANTIANGIOGENICS; DCE-RM; PET; CT FUNCIONAL; ULTRA-SOM |
| 31/68 | US=35 / Biol/Mol LoRusso PM, Bekele BN, Boerner SA, Davis DW, Evelhoch JL, Herbst RS. Phase 1 trials today. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 553-70. ISBN 978-1-4160-3703-3. |
| 32/68 | US=27 / Imagem Khoo VS, Dearnaley DP. The testing of prostate IGRT in clinical trials. In: Valicenti RK, Dicker AP, Jaffray DA. Image-guided radiation therapy of prostate cancer. New York: Informa Helthcare, 2008. p. 233-47. ISBN 978-1-420-06078-2. IMAGEM; CANCER DE PROSTATA; RADIOTERAPIA GUIADA POR IMAGEM; TESTE DE PROSTATA; IGRT; ENSAIOS CLINICOS |
| 33/68 | US=65 / Biol/Mol Fingleton B. MMP inhibitor clinical trials-the past, present, and future. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 759-85. ISBN 978-0-387-69056-8. |
| 34/68 | US=67 / Biol/Mol Easton JB, Houghton PJ. mTOR: properties and therapeutics. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 33-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. MTOR; PROPRIEDADES; TERAPEUTICA; INIBIDORES; RAPAMICINA; CANCER; ENSAIOS CLINICOS |
| 35/68 | US=67 / Biol/Mol Perales MA, Wolchok JD, Kaufman HL. Vaccines as targeted cancer therapy. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 447-69. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. |
| 36/68 | US=67 / Biol/Mol Dubey S, Schiller JH. Clinical trial design with targeted agents. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 649-55. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. ESTUDO CLINICO; AGENTES DIRECIONADOS; ENSAIOS CLINICOS; AGENTES ALVOS |
| 37/68 | US=67 / Imagem Murphy PS, Roychowdhury D. Incorporating imaging into drug development: and industry perspective. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 1-15. ISBN 978-0-470-11880-1. CANCER DE PULMAO; IMAGEM; DESENVOLVIMENTO DE DROGAS; BIOMARCADORES; ENSAIOS CLINICOS |
| 38/68 | US=67 / Imagem Pearson J, Tarbox L, Paladini G, Wolodzko JG, Jacobs PM, Lee Z. Emerging radiological software standards and development technologies: impact on clinical translation and trials. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 67-93. ISBN 978-0-470-11880-1. PADROES RADIOLOGICOS EMERGENTES; SOFTWARE; TECNOLOGIAS DE DESENVOLVIMENTO; TRADUCAO; ENSAIOS CLINICOS |
| 39/68 | US=69 / Câncer Gibbons DL, Wolff RA, Varadhachary G. Targeted drug therapy in pancreatic cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 271-87. ISBN 978-1-60327-423-4. TERAPIA MEDICAMENTOSA ALVO DE CANCER DE PANCREAS; TERAPIA-ALVO; CANCER DE PANCREAS; QUIMIOTERAPIA; ENSAIOS CLINICOS |
| 40/68 | US=69 / Câncer Camacho LH. Drug development in cancer medicine: challenges for targeted approaches. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 383-410. ISBN 978-1-60327-423-4. DESENVOLVIMENTO DE DROGAS EM CANCER; TERAPIA-ALVO; DESAFIOS; OBSTACULOS; DESENVOLVIMENTO DE DROGAS; ENSAIOS CLINICOS; FASE I |